For founders solving biological, medical, and healthcare problems using innovative applications of cell and gene therapies, biologics, antibody-drug conjugates, and other biological products.
The Advanced Therapies global stream admits an annual cohort of pre-Seed and Seed stage startups. The program brings together entrepreneurs, investors, and scientists with expertise building scalable companies in a variety of fields related to biology, medicine, and healthcare.
CDL startups work with these mentors to sharpen objectives, prioritize time and resources, raise capital, and engage with experts working on the frontiers of research.
The startups attend five in-person objective-setting sessions between October and June. CDL is a non-profit organization. There are no fees for participation and CDL does not take any equity. Learn more about the CDL program.
The Advanced Therapies Stream is particularly suited to founders who are on the cutting edge of health therapeutics innovation, utilizing biological products and related technologies to build viable and commercialized therapeutics. This stream is tailored towards early-stage companies (early venture or growth) or even projects (pre-incorporation); however, startups at all levels of maturity will be considered.
Example Innovation Areas
The list above is not exhaustive. Contact email@example.com to discuss the program and your venture with someone from the Advanced Therapies Stream.
Extended Application Deadline: August 28, 2022 @ 11:59PM ET
CDL mentors include accomplished entrepreneurs, experienced operators, active angel and venture investors, world-leading scientists, engineers, and economists. Mentors meet every eight weeks to help founders set objectives over the program’s nine-month duration.
CDL-Berlin Health and CDL Advanced Therapies will continue to accept applications until August 28, 2022 @ 11:59PM ET